![]() |
|||||
Molecular Genetics of Metabolism and Development in C. elegansThe Caenorhabditis elegans model system
During animal development, cells of various identities must coordinate to organize themselves into functional structures. The overarching goals of the Hanna-Rose lab are to elucidate fundamental mechanisms of how development is genetically programmed and controlled and how the development of the animal body plan is coordinated among organs and throughout the organism. We study development of the reproductive structures in the nematode Caenorhabditis elegans as models to address questions of how development is controlled. The nematode C. elegans is a simple organism with few cells. Yet, its development and physiology are sufficiently complex to represent the major mechanisms in animal development and homeostasis. The invariant cell lineage provides a reproducible background for deducing the molecular intricacies of complex processes with cellular resolution. C. elegans has been a valuable model for probing the impact of metabolism in aging and health and principles deduced in this system are relevant to higher organisms, including humans. By studying how and why development in C. elegans goes awry, we propose that we will gain insight into the causes of developmental disease, such as birth defects, in humans. Research Projects
1. Biological roles of NAD+ salvage biosynthesis in cell survival and development
Nicotinamide (NAM) and nicotinic acid (NA) are forms of the essential vitamin B3, which has therapeutic effects in diseases such as diabetes, stroke and coronary artery disease. NAM and NA are precursors for biosynthesis of nicotinamide adenine dinucleotide (NAD+). NAD+ is a central molecule in cellular metabolism and a co-substrate for NAD+ consuming enzymes that regulate key biological processes, such as longevity and stress responses. NAD+ and NAM each regulate the enzymatic activity of these NAD+ consumers, eliciting specific biological responses.
Nicotinamide (NAM) and nicotinic acid (NA) are forms of the essential vitamin B3, which has therapeutic effects in diseases such as diabetes, stroke and coronary artery disease. NAM and NA are precursors for biosynthesis of nicotinamide adenine dinucleotide (NAD+). NAD+ is a central molecule in cellular metabolism and a co-substrate for NAD+ consuming enzymes that regulate key biological processes, such as longevity and stress responses. NAD+ and NAM each regulate the enzymatic activity of these NAD+ consumers, eliciting specific biological responses. Serious dietary deficiency of vitamin B3 causes pellagra in humans, which results in life-threatening abnormalities in skin, brain and gastro-intestinal tract functions. While the biochemistry of NAD+ salvage from vitamin B3 precursors is well studied, and the biological impacts of disruption of this biosynthetic pathway can be easily observed, the molecular mechanisms that mediate the dramatic effects on organ function, including whether perturbed NAD+ or metabolite levels are causative, are still mysterious. We use the C. elegans model to investigate the biology of NAD+ metabolism.
We have made the novel discovery that mutation of the first enzyme in the NAM to NAD+ salvage pathway, PNC-1 nicotinamidase in C. elegans, has specific biological roles during development. Mutations in PNC-1 cause developmental and functional defects in the reproductive system of hermaphrodites and males; the development of the gonad is delayed in both sexes, four uterine cells die by necrosis, the male spicules are crumpled, the hermaphrodites are egg-laying defective, and the males cannot mate. There has been considerable debate over the relative importance of salvage activity modulation of NAM levels versus NAD+ levels in vivo. We have made an important contribution to this open question by showing that the developmental delay of the gonad and the necrosis of the uv1 cells are separable phenotypes that result in the absence of PNC-1 activity from depletion of the salvage pathway product (NAD+) or accumulation of PNC-1 substrate (nicotinamide), respectively. Thus, regulation of substrate as well as product level is key to the biological activity of PNC-1. We have also identified a secreted form of the enzyme and demonstrated its function in vivo. Because nicotinamide phosphoribosyltransferease (Nampt), the equivalent enzyme involved in nicotinamide recycling to NAD+ in vertebrates, is also secreted, we postulate an evolutionarily conserved extracellular role for NAD+ biosynthetic enzymes and are investigating this idea. Ongoing studies are aimed at investigating other enzymes in the salvage pathway and determining the NAD+ consumers that mediate the specific developmental phenotypes
2. Gene Regulation in C. elegans By identifying and studying genetic suppressors of egl-13, which is a Sox domain transcription factor important for maintenance of uterine seam cell fate, we have revealed a novel function for the HIM-8 zinc finger protein and the related ZIM proteins in gene regulation (Nelms and Hanna-Rose, 2006 and Sun et al., 2007). Mutations in the zinc fingers of HIM-8 can suppress missense mutations in the DNA binding domain, but not null alleles, of EGL-13 and every other transcription factor that we have tested. Prior to our work, HIM-8 was believed to act exclusively in chromosome segregation during meiosis; HIM-8 promotes pairing of the X chromosomes, while ZIM-1, ZIM-2 and ZIM-3 control pairing of the autosomes. We used genetic analyses to prove that HIM-8 acts independently of the germ line to antagonize the activity of EGL-13; neither the germ line nor compromised pairing of the X chromosomes is required to observe EGL-13 suppression upon mutation of HIM-8. Furthermore, the meiotic and somatic roles are separable; there are mutations in HIM-8 that compromise pairing but not gene regulatory activity. This gene regulatory activity of HIM-8 is shared among the related ZIM proteins. Mutations in the zim genes can also suppress missense mutations in transcription factors. We are actively pursuing experiments to determine the unusual mechanism whereby this novel family of genes regulates somatic gene activity.
Representative Publications:
Search the MEDLINE database at PubMed for articles by W Hanna-Rose |
|||||
| ©2005 Penn State University Department of Biochemistry & Molecular Biology, 108 Althouse Lab, University Park, PA 16802. Privacy and legal statements. |